The results showed that these four genes were overexpressed in liver cancer tissues, and EFTUD2, GAPDH, NOP56 had high methylation levels in normal tissues, indicating that these genes could be used as biomarkers for liver cancer. The gene discussed is GAPDH; the disease is liver cancer.